Insider transactions

EDGAR

MUSTANG BIO, INC.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-22.

Open-market purchases (code P)
1 transactions, 247 shares
Sum of shares × price per share: 237.614
Open-market sales (code S)
2 transactions, 251 shares
Sum of shares × price per share: 241.4332

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–5 of 5

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-04-24 Filed 2026-04-27Litchman Manuel MD Director · Officer: President, CEO and Interim CFO
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

COMMON STOCK
Disposed (D)190.75
14.25

Derived: shares × price per share. Exact value 14.25.

1,615Direct (D) No
F1
  • F1 19 shares of common stock were relinquished to cover tax liability associated with the delivery of shares of common stock upon the vesting of restricted stock units.
Open filing 0001104659-26-049430 Read from the filing’s XML Dispute this row
2026-01-02 Filed 2026-01-05Fortress Biotech, Inc. 10% owner
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

COMMON STOCK, PAR VALUE $0.0001
Acquired (A)278,3850—536,577Direct (D) No
F1
  • F1 The Reporting Person is entitled to an annual dividend on its Class A Preferred Stock equal to 2.5% of the Issuer's fully diluted outstanding capitalization on December 31. 278,385 shares were granted by the Issuer to the Reporting person for the 2025 annual dividend.
Open filing 0001429260-26-000002 Read from the filing’s XML Dispute this row
2025-12-30 Filed 2025-12-30Jin David Director
P

Open market or private purchase of non-derivative or derivative security

COMMON STOCK, PAR VALUE $0.0001
Acquired (A)2470.962
237.614

Derived: shares × price per share. Exact value 237.614.

286Direct (D) No
F1, F2
  • F1 Represents a private purchase of 247 shares of common stock from another member of the board of directors of the Issuer.
  • F2 Effective January 15, 2025, the Issuer effected a one-for-fifty reverse stock split of its common stock (the Reverse Stock Split). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split.
Open filing 0001104659-25-125227 Read from the filing’s XML Dispute this row
2025-12-30 Filed 2025-12-30Chill Adam J. Director
S

Open market or private sale of non-derivative or derivative security

COMMON STOCK, PAR VALUE $0.0001
Disposed (D)40.9548
3.8192

Derived: shares × price per share. Exact value 3.8192.

375Direct (D) No
F1
  • F1 Effective January 15, 2025, the Issuer effected a one-for-fifty reverse stock split of its common stock (the Reverse Stock Split). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split.
Open filing 0001104659-25-125232 Read from the filing’s XML Dispute this row
2025-12-30 Filed 2025-12-30Herskowitz Neil Director
S

Open market or private sale of non-derivative or derivative security

COMMON STOCK, PAR VALUE $0.0001
Disposed (D)2470.962
237.614

Derived: shares × price per share. Exact value 237.614.

145Direct (D) No
F1, F2
  • F1 Represents a private sale of 247 shares of common stock to another member of the board of directors of the Issuer.
  • F2 Effective January 15, 2025, the Issuer effected a one-for-fifty reverse stock split of its common stock (the Reverse Stock Split). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split.
Open filing 0001104659-25-125233 Read from the filing’s XML Dispute this row

Latest reported holdings

What each reporting owner last said they hold, as of the date shown. A transaction not yet filed is not in it.

Latest reported holdings
Reporting ownerSecurityShares owned afterDirect or indirectSource
Chill Adam J. DirectorCOMMON STOCK, PAR VALUE $0.0001 375D As of 2025-12-30 Open filing 4
Fortress Biotech, Inc. 10% ownerCOMMON STOCK, PAR VALUE $0.0001 6,552,784D As of 2025-01-03 Open filing 3
Fortress Biotech, Inc. 10% ownerCOMMON STOCK, PAR VALUE $0.0001 536,577D As of 2026-01-02 Open filing 4
Herskowitz Neil DirectorCOMMON STOCK, PAR VALUE $0.0001 145D As of 2025-12-30 Open filing 4
Jin David DirectorCOMMON STOCK, PAR VALUE $0.0001 286D As of 2025-12-30 Open filing 4
Litchman Manuel MD Director · Officer: President, CEO and Interim CFOCOMMON STOCK 1,615D As of 2026-04-24 Open filing 4

Joint filers each report the same shares, so rows are not added together.

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.

Showing 1–21 of 21

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
Kestra Advisory Services, LLC 162,620 SH75,293 dollarsLower by 34,371 Prior quarter: 196,991Open filing 0001830819-26-000012 Filed 2026-11-19 Dispute this row
BlackRock, Inc. Partly reported under another manager84,745 SH39,237 dollarsUnchanged Prior quarter: 84,745Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager70,062 SH32,439 dollarsHigher by 10,603 Prior quarter: 59,459Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager40,630 SH18,811 dollarsLower by 1,610 Prior quarter: 42,240Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
CFO4Life Group, LLC Partly reported under another manager33,510 SH15,515 dollarsUnchanged Prior quarter: 33,510Open filing 0001765380-26-000480 Filed 2026-11-12 Dispute this row
VANGUARD FIDUCIARY TRUST CO 32,120 SH14,872 dollarsUnchanged Prior quarter: 32,120Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 25,704 SH11,901 dollarsUnchanged Prior quarter: 25,704Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
XTX Topco Ltd Partly reported under another manager12,986 SH6,013 dollarsLower by 1,662 Prior quarter: 14,648Open filing 0001828301-26-000009 Filed 2026-11-16 Dispute this row
StoneX Group Inc. Partly reported under another manager11,604 SH6,143 dollarsNot in the prior quarter’s filings read Open filing 0000913760-26-000042 Filed 2026-11-03 Dispute this row
Tower Research Capital LLC (TRC) Partly reported under another manager1,886 SH873 dollarsLower by 9 Prior quarter: 1,895Open filing 0001533421-26-000010 Filed 2026-11-16 Dispute this row
UBS Group AG Partly reported under another manager692 SH320 dollarsLower by 3,463 Prior quarter: 4,155Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
SBI Securities Co., Ltd. 509 SH236 dollarsUnchanged Prior quarter: 509Open filing 0001851815-26-000004 Filed 2026-10-22 Dispute this row
MORGAN STANLEY Partly reported under another manager118 SH55 dollarsUnchanged Prior quarter: 118Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
Cullen/Frost Bankers, Inc. Partly reported under another manager13 SH6 dollarsUnchanged Prior quarter: 13Open filing 0000039263-26-000051 Filed 2026-10-28 Dispute this row
Global Retirement Partners, LLC 11 SH5 dollarsNot in the prior quarter’s filings read Open filing 0001580642-26-007620 Filed 2026-11-10 Dispute this row
BNP PARIBAS FINANCIAL MARKETS Partly reported under another manager6 SH3 dollarsUnchanged Prior quarter: 6Open filing 0001166588-26-000012 Filed 2026-11-12 Dispute this row
LANARK FINANCIAL, INC. 3 SH1 dollarsUnchanged Prior quarter: 3Open filing 0000791540-26-000020 Filed 2026-10-26 Dispute this row
FMR LLC Partly reported under another manager2 SH1 dollarsNot in the prior quarter’s filings read Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
DANSKE BANK A/S 2 SH1 dollarsUnchanged Prior quarter: 2Open filing 0001104659-26-124081 Filed 2026-11-09 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager2 SH1 dollarsUnchanged Prior quarter: 2Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
OSAIC HOLDINGS, INC. Partly reported under another manager2 SH0 dollarsUnchanged Prior quarter: 2Open filing 0001677044-26-000011 Filed 2026-11-12 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Virtu Financial LLC 14,356 SH
  • TWO SIGMA SECURITIES, LLC 13,742 SH
  • SUSQUEHANNA INTERNATIONAL GROUP, LLP 13,664 SH
  • BARCLAYS PLC 1,121 SH
  • GROUP ONE TRADING LLC 1 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text; they are read only when their rows add up to the totals the filer states.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Institutional ownership reported on Form 13F

13F filers report holding between 2.14% and 6.29% of shares outstanding.

Quarter ending 2026-09-30, against 7,584,078 shares on the cover dated 2026-11-03. The count is all classes added together.

  • The lower figure counts positions a manager reports as its own with sole discretion. The upper figure counts every plain-share position and can count a share twice.
  • Neither includes holders that do not file Form 13F, or managers below the filing threshold.
Quarter-by-quarter 13F holders
QuarterManagers holdingShares, at leastShares, at mostFilings read
2026-09-30 21162,636477,2278,935
2026-06-30 23210,739539,0069,178
2026-03-31 22192,804508,0329,173
2025-12-31 25163,918551,9689,222
2025-09-30 2166,113280,6088,469
2025-06-30 18574,2648,516
2025-03-31 175113,8618,518
2024-12-31 313,812,7544,670,9058,580

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read from their tags. Earlier schedules are free text: they are read only when every cover page states a share count and a percent, and the rest are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Fortress Biotech, Inc. Common Stock, $0.0001 Par Value8.0537,243.0001/02/2026 Filed 2026-01-05SCHEDULE 13D/AAmendment 7Open filing 0001104659-26-000690 Dispute this row
Fortress Biotech, Inc. Common Stock, $0.0001 Par Value4.0258,858.0009/29/2025 Filed 2025-10-01SCHEDULE 13D/AAmendment 6Open filing 0001104659-25-095631 Dispute this row
Mitchell P. Kopin Common stock, par value $0.0001 per share4.99185,527.0006/30/2025 Filed 2025-08-12SCHEDULE 13G/AAmendment 2Open filing 0001213900-25-075080 Dispute this row
Daniel B. Asher Common stock, par value $0.0001 per share4.99185,527.0006/30/2025 Filed 2025-08-12SCHEDULE 13G/AAmendment 2Open filing 0001213900-25-075080 Dispute this row
Intracoastal Capital LLC Common stock, par value $0.0001 per share4.99185,527.0006/30/2025 Filed 2025-08-12SCHEDULE 13G/AAmendment 2Open filing 0001213900-25-075080 Dispute this row
Armistice Capital, LLC Common Stock, par value $0.0001 per share4.991,911,086— Filed 2024-11-14SC 13G/AAmendment 1Read from the cover page textOpen filing 0001172661-24-005232 Dispute this row
Steven Boyd Common Stock, par value $0.0001 per share4.991,911,086— Filed 2024-11-14SC 13G/AAmendment 1Read from the cover page textOpen filing 0001172661-24-005232 Dispute this row
Armistice Capital, LLC Common Stock, par value $0.0001 per share9.99974,907— Filed 2024-02-14SC 13GRead from the cover page textOpen filing 0001172661-24-001376 Dispute this row
Steven Boyd Common Stock, par value $0.0001 per share9.99974,907— Filed 2024-02-14SC 13GRead from the cover page textOpen filing 0001172661-24-001376 Dispute this row
BlackRock, Inc. Common Stock2.22,263,156— Filed 2022-07-08SC 13GRead from the cover page textOpen filing 0000834237-22-010335 Dispute this row
BlackRock, Inc. Common Stock6.25,754,566— Filed 2022-02-04SC 13GRead from the cover page textOpen filing 0000834237-22-007086 Dispute this row
BlackRock, Inc. Common Stock4.73,984,922— Filed 2021-04-12SC 13G/AAmendment 1Read from the cover page textOpen filing 0000834237-21-008084 Dispute this row
BlackRock, Inc. Common Stock5.23,344,681— Filed 2021-02-02SC 13GRead from the cover page textOpen filing 0000834237-21-006826 Dispute this row
City of Hope Common Stock, par value $0.0001 per share5.11,293,588— Filed 2017-02-14SC 13GRead from the cover page textOpen filing 0001193125-17-043602 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

3,092,627 filings read, dated 1980-01-02 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015246,723
2016246,472
2017244,814
2018245,575
2019238,619
2020249,093
2021274,850
2022257,922
2023253,676
2024261,106
2025235,525
2026263,830

Filings made before the SEC required XML are listed, not extracted.

Back to MUSTANG BIO, INC.